logo

Takeda Pharmaceutical Company Limited (TAK)



Trade TAK now with
  Date
  Headline
5/29/2020 8:08:17 AM Takeda To Present Interim Analysis Data From Phase 2 OPTIC Trial
5/26/2020 9:01:41 AM Medical Researchers, Life Science Companies, COVID-19 Survivors Launch National Campaign To Drive Blood Plasma Donation
5/14/2020 8:15:51 AM Takeda: European Commission Approves ADCETRIS For Treatment Of Adult Patients With Previously Untreated SALCL
5/13/2020 2:22:12 AM Takeda FY19 Reported Revenue Up 56.9% To 3.29 Trln Yen
5/8/2020 2:08:18 AM Takeda:EU Oks SC Of Entyvio For Use As Maintenance Therapy With Moderately To Severely Active Ulcerative Colitis
4/27/2020 8:05:42 AM Takeda Reports FDA Breakthrough Therapy Designation For TAK-788 For NSCLC Patients With EGFR Exon 20 Insertion Mutations
4/23/2020 9:24:59 AM ProThera Biologics And Takeda Enter Global Licensing Agreement To Develop Novel Plasma-derived IAIP Therapy
4/6/2020 8:07:43 AM Takeda Says EC Extended Current Marketing Authorization Of ALUNBRIG To Include Use As Monotherapy For ALK+ NSCLC
4/6/2020 6:50:12 AM Biotest, BPL, LFB, And Octapharma Collaborate To Accelerate Development Of Potential COVID-19 Hyperimmune Therapy
4/6/2020 1:28:23 AM Evotec GT Establishes Long-term Research Alliance With Takeda
3/31/2020 10:04:11 PM Takeda Adopts Executive Compensation Recoupment Policy
3/31/2020 8:04:00 AM Takeda Receives Positive CHMP Opinion For ADCETRIS(r) In Combination With CHP